Chelation Therapy for Treatment of Atherosclerosis

EDTA chelation therapy for treatment or prevention of atherosclerosis is regarded as experimental and is not covered. Claims for chelation therapy filed under variant terms (e.g., chemoendarterectomy) or alternative diagnoses such as arteriosclerosis or calcinosis should also be denied because safety and clinical effectiveness have not been established.

"EDTA chelation therapy for the treatment or prevention of atherosclerosis is considered experimental and is not covered."

Sign up to see full coverage criteria, indications, and limitations.